ESMA registers SPMW Rating Sp. z o.o. as a CRA

The European Securities and Markets Authority (ESMA), the EU’s direct supervisor of credit rating agencies (CRAs), has registered SPMW Rating Sp. z o.o. as a CRA under Regulation (EC) No 1060/2009 of the European Parliament and of the Council of 16 September 2009 on credit rating agencies (CRA Regulation), with effect from 15 March 2018. SPMW Rating Sp. z o.o. is based in Poland, issuing sovereign and public finance ratings and corporate ratings.

The CRA Regulation seeks to ensure that credit ratings issued in the EU respect minimum standards of quality, transparency and independence by providing that only companies registered by ESMA as CRAs may lawfully issue credit ratings which can be used for regulatory purposes by credit institutions, investment firms, insurance and reinsurance undertakings, institutions for occupational retirement provision, management companies, investment companies, alternative investment fund managers and central counterparties.

In order to be registered as a CRA a company must be able to demonstrate to ESMA that it can comply with the requirements of the CRA Regulation, including, most importantly, on:

  • the governance of CRAs and the management of conflicts of interest;
  • the development and application of methodologies for assessing credit risk; and
  • the disclosure of information to ESMA and to market participants.

Once registered, CRAs are subject to on-going supervision and monitoring by ESMA to make sure that they continue to meet the conditions for registration. ESMA will impose sanctions and/or penalties where it finds that a CRA has failed to meet its obligations under the CRA Regulation.

The SPMW Rating Sp. z o.o. registration brings the total number of CRAs registered in the EU to 27 CRAs. Amongst the 27 registered CRAs, three operate under a group structure, totalling 17 legal entities in the EU, which means that the total number of CRA entities registered in the EU is 41.



ESMA registers SPMW Rating Sp. z o.o. as a CRA

The European Securities and Markets Authority (ESMA), the EU’s direct supervisor of credit rating agencies (CRAs), has registered SPMW Rating Sp. z o.o. as a CRA under Regulation (EC) No 1060/2009 of the European Parliament and of the Council of 16 September 2009 on credit rating agencies (CRA Regulation), with effect from 15 March 2018. SPMW Rating Sp. z o.o. is based in Poland, issuing sovereign and public finance ratings and corporate ratings.

The CRA Regulation seeks to ensure that credit ratings issued in the EU respect minimum standards of quality, transparency and independence by providing that only companies registered by ESMA as CRAs may lawfully issue credit ratings which can be used for regulatory purposes by credit institutions, investment firms, insurance and reinsurance undertakings, institutions for occupational retirement provision, management companies, investment companies, alternative investment fund managers and central counterparties.

In order to be registered as a CRA a company must be able to demonstrate to ESMA that it can comply with the requirements of the CRA Regulation, including, most importantly, on:

  • the governance of CRAs and the management of conflicts of interest;
  • the development and application of methodologies for assessing credit risk; and
  • the disclosure of information to ESMA and to market participants.

Once registered, CRAs are subject to on-going supervision and monitoring by ESMA to make sure that they continue to meet the conditions for registration. ESMA will impose sanctions and/or penalties where it finds that a CRA has failed to meet its obligations under the CRA Regulation.

The SPMW Rating Sp. z o.o. registration brings the total number of CRAs registered in the EU to 27 CRAs. Amongst the 27 registered CRAs, three operate under a group structure, totalling 17 legal entities in the EU, which means that the total number of CRA entities registered in the EU is 41.



ESMA registers SPMW Rating Sp. z o.o. as a CRA

Download PDF


ESMA registers SPMW Rating Sp. z o.o. as a CRA

Download PDF


Press release: Keep head lice treatments away from naked flame

Parents, caregivers and people with head lice are being reminded to always read product instructions before applying head lice removal products. Some of these products have the potential to ignite when in the presence of an open flame – such as when lighting cigarettes.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Drug Safety Alert advising pharmacists to tell people about the risk of fires when they discuss options to treat head lice.

With some head lice removal products easily accessible at supermarkets and without a pharmacist’s guiding hand, users need to be aware of the importance of reading the instructions that come with all treatments to make sure they are used safely and correctly.

Speak with a pharmacist to discuss the advantages and disadvantages of each treatment option. Alternatively see NHS Choices page on Head lice and nits and the Head lice Clinical Knowledge Summary from NICE for more information on options for eradication.

Dr Sarah Branch, Deputy Director of MHRA’s Vigilance and Risk Management of Medicines (VRMM) Division said:

It’s important parents and carers know always to keep away from a naked flame, including cigarettes, when using these head lice treatments. People can continue to use these head lice removal products safely – like all medical products, a simple check of the instructions will ensure safe, easy and effective use.

Patient safety is our highest priority and we encourage people to report any incidents involving head lice removal products to MHRA using our Yellow Card Scheme.

Notes to Editor

  • A range of products, which can include products like Hedrin, Full Marks, and Nyda, are used for the eradication of head lice infestations.
  • 10 cases of serious burns associated with the use of head lice removal products have been reported to our Yellow Card Scheme since 2007.
  • Some products for the removal of head lice can ignite when on the hair and cause serious harm in the presence of an open flame or other source of ignition such as when lighting cigarettes.
  • Instructions for use should always be followed, including warnings to keep hair away from naked flame when using these products.
  • Pharmacists are encouraged to help the person with head lice and/or their parents or caregivers to consider the advantages and disadvantages of each treatment option (see NHS Choices page on Head lice and nits and the Head lice Clinical Knowledge Summary from NICE for more information on options for eradication).